This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2022-2025.
Company Filing History:
Years Active: 2022-2025
Title: Innovations by Kristopher Kopacz
Introduction
Kristopher Kopacz is an accomplished inventor based in Cumberland, RI (US). He has made significant contributions to the field of biopharmaceuticals, particularly in the development of bispecific antibodies. With a total of 2 patents, his work focuses on addressing critical health issues.
Latest Patents
Kopacz's latest patents include bispecific antibodies against plasma kallikrein and factor XII. These antibodies are designed to bind to plasma kallikrein (pKal) and Factor XII, providing methods for producing and utilizing these bi-specific antibodies. They are aimed at treating diseases or disorders associated with the contact system, such as hereditary angioedema or thrombosis.
Career Highlights
Kristopher Kopacz is currently employed at Takeda Pharmaceutical Company Limited, where he continues to innovate in the field of biopharmaceuticals. His work has the potential to significantly impact the treatment of various medical conditions.
Collaborations
Kopacz collaborates with notable colleagues, including Stephen R Comeau and Andrew Nixon. Their combined expertise enhances the research and development efforts within their projects.
Conclusion
Kristopher Kopacz's contributions to the field of biopharmaceuticals through his innovative patents and collaborations highlight his role as a key inventor in advancing medical treatments. His work continues to pave the way for new therapeutic options.